摩根大通：将拜耳评级从“中性”上调至“超配”；目标价从25欧元上调至50欧元。

Group 1 - Morgan Stanley upgraded Bayer's rating from "Neutral" to "Overweight" [1] - The target price for Bayer was raised from €25 to €50 [1]